Medical and Social Expert Evaluation and RehabilitationMedical and Social Expert Evaluation and Rehabilitation1560-95372412-2092Eco-Vector3564310.17816/MSER35643Research ArticleThe modern possibilities of diagnostics, treatment and rehabilitation of patients with variant forms of autoimmune diseases of liverBurnevitchE. Z-ArionE. A-AleksandrovaE. A-15122011144363921072020Copyright © 2011, Eco-Vector2011The patients with established autoimmune hepatitis having alkaline phosphatase or alkaline phosphatase/AST correlation increase more than 1,5 and whose conditions didn 7 improve after immunasuppressor treatment should undergo ERCP or MRT cholangiography to identify the primary sclerosing cholangitis or AM A and to verify the possible primary biliary cirrhosis. On the other side, a range of patients with PBC and PSC had a high activity of hepatic processes that can be caused by combined autoimmune hepatitis. A combined therapy of immunosuppressor and ursodeoxycholic acid can impact the disease prognosis.hepatitisautoimmune diseasesгепатитаутоиммунные заболевания[Alvarez F., Berg P.A., Bianchi F.В. et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis // J. Hepatol. - 1999. - Vol. 31. - P. 929-938.][Ben-Ari Z., Dhillon A.P., Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis // Hepatology. - 1993. - Vol. 18. - P. 10-15.][Berg P.A., Klein R. Mitochondrial antigen/antibody systems in primary biliary cirrhosis; revisited // Liver. - 1995. - Vol. 15. - P. 281-292.][Brunner G., Klinge O. Ein der chronich-destruirenden nicht-eitrigen Cholangitis ahnliches Krankheitsbild mit antinuclearen Antikorpem (Immuncholangitis) j j Dtsch. Med. Wschr. - 1987. - Bd 112. - S. 1454-1458.][Czaja A.J. Autoimmune hepatitis. Evolving concepts and treatment strategies // Dig. Dis. Sci. - 1995. - Vol. 40. - P. 435-456.][Fussey S.P., Ali S.Т., Guest J.R. et al. Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydroiipoamide acetyltransferase (E2p): characterisation of the main immunogenic region // Proc. Natl Acad. Sci. USA. - 1990. - Vol. 87. - P. 3987-3991.][Fussey S.P., Guest J.R., James O. et al. Identification and analysis of the major М2 autoantigens in primary biliary cirrhosis // Proc. Natl Acad. Sci. USA. - 1988. - Vol. 85. - P. 8654-8658.][Gershwin M.E., Mackay I.R., Sturgess A., Coppel R.L. Identification and specificity of a cDNA encoding the 70 kD mitochondrial antigen recognised in primary biliary cirrhosis // J. Immunol. - 1987. - Vol. 138. - P. 3525-3531.][Invernizzi P., Crosignani A., Battezzati P.M. et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis // Hepatology, - 1997. - Vol. 25. - P. 1090-1095,][Kaplan M.M. Primary biliary cirrhosis // N. Engl. J. Med. - 1996. - Vol. 335. - P. 1570-1580.][Kim W.R., Poterucha J.J., Jorgensen R.A. et al. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? // Hepatology. - 1997. - Vol. 26. - P. 22-26.][Kitami N., Komada T., Ishii H. et al. Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis // Intern. Med. - 1995. - Vol. 34. - P. 496-501.][Krams S.М., Van de Water J., Coppei R.L. et al. Analysis of hepatic T-lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis // Hepatology. - 1990. - Vol. 12. - P. 306-313.][Lacerda M.A., Ludwig J., Dickson E.R. et al. Antimitochondrial antibody-negative primary biliary cirrhosis // Am. J. Gastroenterol. - 1995. - Vol. 90. - P. 247-249.][Michieletti P., Bassendine M.F., Heathcote E.J. et al. Antimitichondrial antibody negative primary biliary cirrhosis or autoimmune cholangitis? // Hepatology. - 1992. - Vol. 16. - P. 568.][Michieletti P., Wanless I.R., Katz A. et al, Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis // Gut, - 1994. - Vol. 35. - P. 260-265.][Miyakawa H., Tanaka A., Kikuchi K. et al. Detection of antimitochon drial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens // Hepatology. - 2001. - Vol. 34. - P. 243-248.][Mutimer D.J., Fussey S.P., Yeaman S.J. et al. Frequency of IgG and IgM autoantibodies to four specific М2 mitochondrial autoantigens in primary biliary cirrhosis // Hepatology. - 1989. - Vol. 10. - P. 403-407.][Nakanuma Y., Harada K., Kaji K. et al. Clinicopathological study of primary biliary cirrhosis negative for antimitochondrial antibodies // Liver. - 1997. - Vol. 17. - P. 281-287.][Nishio A., Van de Water J., Leung P.S.C. et al. Comparative studies of antimitichondrial autoantibodies in sera and bile in primary biliary cirrhosis // Hepatology. - 1997. - Vol. 25. - P. 1085-1089.][O’Donohue J., Williams R. Antimitochondrial antibody and primary biliary cirrhosis: can there be one without the other? // J. Hepatol. - 1996. - Vol. 25. - P. 574-577.][Ponsioen C.I., Tytgat G.N. Primary sclerosing cholangitis: a clinical review // Am. J. Gastroenterol. - 1998. - Vol. 93. - P. 515-523.][Sherlock S., Scheuer P.J. The presentation and diagnosis of 100 patients with primary biliary cirrhosis // N. Engl. J. Med. - 1973. - Vol. 289. - P. 674-678.][Tsuneyama K., Van De Water J., Van Thiel D. et al. Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis // Hepatology. - 1995. - Vol. 22. - P. 1440-1146.][Van de Water J., Surh C.D., Leung P.S. et al. Molecular definitions, autoepitopes, and enzymatic activities of the mitochondrial autoantigens of primary biliary cirrhosis // Semin. Liver Dis. - 1989. - Vol. 9, - P. 132-137.][Van de Water J., Turchany J., Leung P.S. et al. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial exspression of a molecule cross-reactive with piruvate dehydrogenase complex-E2 // J. Clin. Invest. - 1993. - Vol. 91. - P. 2653-2664.]